Skip to main content
Clinical Trials/ISRCTN57930977
ISRCTN57930977
Completed
未知

Prospective, non-randomised, multicentre, observational study to further support safety and efficacy of the Misago® peripheral self-expanding stent system in real-world patients

Terumo Europe N.V. (Belgium)0 sites2,000 target enrollmentNovember 30, 2009

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Terumo Europe N.V. (Belgium)
Enrollment
2000
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 30, 2009
End Date
TBD
Last Updated
8 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Terumo Europe N.V. (Belgium)

Eligibility Criteria

Inclusion Criteria

  • Patients aged greater than 18 years, either sex, that as per hospital practice are treated with a self\-expanding nitinol stent

Exclusion Criteria

  • Does not meet inclusion criteria

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Prospective, non-randomised, multi-centre, observational study to confirm the performance of Misago® peripheral self-expanding stent system for the treatment of occluded or stenotic superficial femoral or popliteal arteriesOccluded or stenotic superficial femoral and/or popliteal arteriesCirculatory SystemArterial embolism and thrombosis
ISRCTN58138617Terumo Europe N.V. (Belgium)500
Recruiting
Not Applicable
Prospective, Non-randomized, Multicentre, Observational Registry To confirm the performance of Misago Peripheral Self-Expanding Stent System for the Treatment of Occluded or Stenotic Superficial Femoral or Popliteal Arteries.blockage of arteriesocclusionstenosis10003216
NL-OMON32020Terumo30
Terminated
Not Applicable
Research study of a new miniaturized (reduced size) left-ventricular assist device called Miniaturized Ventricular Assist Device(MVAD 'Registered Trademark' System), which is being developed for the treatment of advanced heart failure.Advanced heart failureCardiovascular - Other cardiovascular diseases
ACTRN12615001036505HeartWare Inc.11
Recruiting
Not Applicable
Impact of incorporating a polygenic risk score into cardiovascular disease examinations on the identification of subclinical coronary artery disease (CAD)Cardiovascular diseaseCardiovascular - Coronary heart disease
ACTRN12622000436774The University of Sydney1,000
Completed
Not Applicable
Prospective, multicenter, non-randomized, single-arm observational study to evaluate safety and effectiveness of iCover covered stent for the treatment of the aorto-iliac Occlusive DiseaseAorto-Iliacal Artheropathy
DRKS00028124IVascular240